Gene Patents and Cancer Voices Author: Matthew Rimmer EAP Date (Approved for Print): 11 December 2013 DOI: 10.5778/JLIS.2013.22.Rimmer.1

Total Page:16

File Type:pdf, Size:1020Kb

Gene Patents and Cancer Voices Author: Matthew Rimmer EAP Date (Approved for Print): 11 December 2013 DOI: 10.5778/JLIS.2013.22.Rimmer.1 Title: The Empire of Cancer: Gene Patents and Cancer Voices Author: Matthew Rimmer EAP Date (approved for print): 11 December 2013 DOI: 10.5778/JLIS.2013.22.Rimmer.1 Note to users: Articles in the ‘Epubs ahead of print’ (EAP) section are peer reviewed accepted articles to be published in this journal. Please be aware that although EAPs do not have all bibliographic details available yet, they can be cited using the year of online publication and the Digital Object Identifier (DOI) as follows: Author(s), ‘Article Title’, Journal (Year), DOI, EAP (page #). The EAP page number will be retained in the bottom margin of the printed version of this article when it is collated in a print issue. Collated print versions of the article will contain an additional volumetric page number. Both page citations will be relevant, but any EAP reference must continue to be preceded by the letters EAP. ISSN-0729-1485 Copyright © 2013 University of Tasmania All rights reserved. Subject to the law of copyright no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise, without the permission of the owner of the copyright. All enquiries seeking permission to reproduce any part of this publication should be addressed in the first instance to: The Editor, Journal of Law, Information and Science, Private Bag 89, Hobart, Tasmania 7001, Australia. [email protected] http://www.jlisjournal.org/ Electronic copy available at: http://ssrn.com/abstract=2368067 Electronic copy available at: http://ssrn.com/abstract=2368067 The Empire of Cancer: Gene Patents and Cancer Voices * MATTHEW RIMMER ‘The empire of cancer spread/across the wrinkled sheets.’ Derek Walcott, Omeros1 In his book, The Emperor of All Maladies, Siddhartha Mukherjee writes a history of cancer — ‘It is a chronicle of an ancient disease — once a clandestine, “whispered-about” illness — that has metamorphosed into a lethal shape-shifting entity imbued with such penetrating metaphorical, medical, scientific, and political potency that cancer is often described as the defining plague of our generation’.2 Increasingly, an important theme in the history of cancer is the role of law, particularly in the field of intellectual property law. It is striking that a number of contemporary policy debates over intellectual property and public health have concerned cancer research, diagnosis, and treatment.3 In the area of access to essential medicines, there has been much debate over Novartis’ patent application in respect of Glivec, a treatment for leukaemia.4 India’s Supreme Court held that the Swiss company’s patent application violated a safeguard provision in India’s patent law designed to stop evergreening.5 In the field of tobacco control, the Australian Government introduced plain * Dr Matthew Rimmer (BA/LLB ANU, Phd UNSW) is an Australian Research Council Future Fellow; an Associate Professor at the ANU College of Law; and an Associate Director of the Australian Centre for Intellectual Property in Agriculture (ACIPA). 1 Derek Walcott, Omeros, (Noonday Press, 1992). 2 Siddhartha Mukherjee, The Emperor of All Maladies: A Biography of Cancer, (Fourth Estate, 2011) xiii. 3 Antony Taubman, A Practical Guide to Working with TRIPS, (Oxford University Press, 2011). 4 ‘Protecting Patents or Patients?’, Inside Story, Al Jazeera (online) 2 April 2013, <http://www.aljazeera.com/programmes/insidestory/2013/04/201341112023248 57.html>. 5 Novartis AG v Union of India (2013), Supreme Court of India, Civil Appeal Nos 2706-2716, 2013, <http://judis.nic.in/supremecourt/imgs1.aspx?filename=40212>. For a commentary, see Hans Lofgren, ‘India’s Novartis Patent Ruling Puts Health Before Profits’, The Conversation (4 April 2013) <http://theconversation.com/indias-novartis-patent-ruling-puts-health-before- profits-13198>. EAP 1 The Empire of Cancer: Gene Patents and Cancer Voices packaging for tobacco products in order to address the health burdens associated with the tobacco epidemic.6 This regime was successfully defended in the High Court of Australia.7 In the area of intellectual property and biotechnology, there have been significant disputes over the Utah biotechnology company Myriad Genetics and its patents in respect of genetic testing for BRCA1 and BRCA2, which are related to breast cancer and ovarian cancer. The Federal Court of Australia handed down a decision on the validity of Myriad Genetics’ patent in respect of genetic testing for BRCA1 in February 2013.8 The Supreme Court of the United States heard a challenge to the validity of Myriad Genetics’ patents in this area in April 2013, and handed down a judgment in July 2013.9 Such disputes have involved tensions between intellectual property rights, and public health.10 This article focuses upon one of these important test cases involving intellectual property, public health, and cancer research. In June 2010, Cancer Voices Australia and Yvonne D’Arcy brought an action in the Federal Court of Australia against the validity of a BRCA1 patent11 — held by Myriad Genetics Inc, the Centre de Recherche du Chul, the Cancer Institute of Japan and Genetic Technologies Limited.12 Yvonne D’Arcy — a Brisbane woman who has had treatment for breast cancer — maintained: ‘I believe that what they are doing is morally and ethically corrupt and that big companies should 6 Tobacco Plain Packaging Act 2011 (Cth). 7 JT International SA v Commonwealth of Australia; British American Tobacco Australasia Limited v The Commonwealth [2012] HCA 43; Matthew Rimmer, ‘Cigarettes will Kill You: The High Court of Australia and the Plain Packaging of Tobacco Products’ (2013) 1 WIPO Magazine 20 <http://www.wipo.int/wipo_magazine/en/2013/01/article_0005.html>; Sam Ricketson, ‘Plain Packaging Legislation for Tobacco Products and Trade Marks in the High Court of Australia’ (2013) 3(3) Queen Mary Journal of Intellectual Property 224; and Jonathan Liberman, ‘Plainly Constitutional: The Upholding of Plain Tobacco Packaging by the High Court of Australia’, (2013) American Journal of Law and Medicine 361. 8 Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65. 9 Materials associated with the case are documented here: Association for Molecular Pathology v Myriad Genetics Inc (2013), the Supreme Court of the United States, 12- 398 <http://www.scotusblog.com/case-files/cases/association-for-molecular- pathology-v-myriad-genetics-inc>; and the judgment is here: Association for Molecular Pathology v Myriad Genetics, Inc, 133 S Ct 2107 (2013). 10 Thomas Pogge, Matthew Rimmer and Kim Rubenstein (eds), Incentives for Global Public Health: Patent Law and Access to Medicines (Cambridge University Press, 2010). 11 Donna Shattuck-Eidens, Jacques Simard, Francine Durocher, Yusuke Nakamura, and Mitsuri Emi (inventors) and Myriad Genetics Inc (Assignee), ‘In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene’, (1994) Australian Patent number 686004. 12 Cancer Voices Australia et al v Myriad Genetics Inc et al (2010), Federal Court of Australia, Statement of Claim, 8 June. EAP 2 Journal of Law, Information and Science Vol 22(2) 2012-2013 not control any parts of the human body.’13 She observed: ‘For my daughter, I've had her have [sic] mammograms, etc, because of me but I would still like her to be able to have the test to see if the mutation gene is in there from me.’14 The applicants made the following arguments: Genes and the information represented by human gene sequences are products of nature universally present in each individual, and the information content of a human gene sequence is fixed. Genetic variations or mutations are products of nature. The isolation of the BRCA1 gene mutation from the human body constitutes no more than a medical or scientific discovery of a naturally occurring phenomenon and does not give rise to a patentable invention.15 The applicants also argued that ‘the alleged invention is not a patentable invention in that, so far as claimed in claims 1–3, it is not a manner of manufacture within the meaning of s 6 of the Statute of Monopolies’.16 The applicants suggested that ‘the alleged invention is a mere discovery’.17 Moreover, the applicants contended that ‘the alleged invention of each of claims 1–3 is not a patentable invention because they are claims for biological processes for the generation of human beings’.18 The applicants, though, later dropped the argument that the patent claims related to biological processes for the generation of human beings. In February 2013, Nicholas J of the Federal Court of Australia considered the case brought by Cancer Voices Australia and Yvonne D’Arcy against Myriad Genetics. The judge presented the issues in the case, as follows: The issue that arises in this case is of considerable importance. It relates to the patentability of genes, or gene sequences, and the practice of “gene patenting”. Briefly stated, the issue to be decided is whether under the Patents Act 1990 (Cth) a valid patent may be granted for a claim that covers naturally occurring nucleic acid — either deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) — that has been “isolated”. In this context, the word “isolated” implies that naturally occurring nucleic acid found in the cells of the human body, whether it be DNA or RNA, has 13 Meredith Griffiths, ‘Breast Cancer Sufferers Take Gene Patents to Court’, AM ABC (8 June 2010) <http://www.abc.net.au/am/content/2010/s2921053.htm>. 14 Ibid. 15 Cancer Voices Australia et al v Myriad Genetics Inc et al (2010), Federal Court of Australia, Statement of Claim, 8 June. 16 Ibid. 17 Ibid. 18 Ibid. EAP 3 The Empire of Cancer: Gene Patents and Cancer Voices been removed from the cellular environment in which it naturally exists and separated from other cellular components also found there. The genes found in the human body are made of nucleic acid.
Recommended publications
  • Managing Gender: the 2010 Federal Election
    21. Managing Gender: The 2010 federal election Marian Sawer1 The 2010 federal election was the first in Australian history in which a woman prime minister was campaigning for the re-election of her government. Paradoxically, her party had no women’s policy—or at least did not launch one publicly. Despite the avoidance of any policy focus on gender issues, gender was a significant undercurrent in the election, as reflected in consistent gender gaps in public opinion and voting intentions. Unusually, the management of gender turned out to be more of a problem for a male than for a female leader. Gender Gaps and Gendered Coverage Gender was expected to feature prominently in the 2010 campaign given the contest between Julia Gillard as Australia’s first woman prime minister and Tony Abbott, a hyper-masculine Opposition leader and ironman triathlete. Abbott’s persona was that of an ‘action man’ always ready to don lycra and a helmet for some strenuous sporting activity; the Coalition campaign slogan was ‘Real action’. Abbott was also known for telling women how to live their lives, criticising them for taking ‘the easy way out’ by having abortions and blocking the importation of abortion drug RU486 while he was Health Minister. While the Abbott action-man persona might have been useful in a contest with Kevin Rudd, who was to be framed as ‘all talk and no action’, it was less useful in a contest with Julia Gillard. It required various forms of softening, particularly through referencing of the women in his life, but also through less-aggressive presentation and promises not to tinker with access to abortion.
    [Show full text]
  • The Hon. Bill Heffernan
    Your Candidate for Senate Preselection THE HON. BILL HEFFERNAN HOLLIE IS THE ONLY CANDIDATE THAT I HAVE EVER KNOWN THROUGHOUT MY LONG TIME IN THE LIBERAL PARTY THAT HAS WON A PRESELECTION, THE PREVIOUS SENATE PRESELECTION, WHERE SHE WAS SELECTED TO LEAD THE TICKET, AND STOOD ASIDE AT THE REQUEST OF THE THEN PRIME MINISTER. SHE STEPPED ASIDE AND CONTINUED TO CAMPAIGN AND FUNDRAISE FROM POSITION 6 ON THE TICKET. AS FORMER STATE MINISTER TED PICKERING SAID TO ME IN MY FIRST PRESELECTION BALLOT AGAINST SENATOR JOHN TIERNEY, WHICH HE WON, “SON, TO RUN FOR THE SENATE, YOU HAVE TO HAVE SERVED YOUR TIME IN THE PARTY”. HOLLIE HAS WELL AND TRULY SERVED HER TIME… About Hollie Hollie Hughes is a long-time resident and community advocate for regional NSW having spent most of the past twenty years living in the country. Until recently, Hollie and her family have been living and working in Moree, in far North West NSW. Hollie understands first-hand the impact of drought, limited social and health services and the needs of our regional communities. Hollie first moved to the country more than two decades ago to study at Charles Sturt University in Bathurst. Majoring in Broadcast Journalism and later completing a Masters of Politics and Public Policy from Macquarie University, Hollie embarked on a successful career in communications, Government affairs and consultancy. For the past two years she has worked as the Head of Government for Executive Search firm Salt & Shein. Throughout her career, Hollie has worked to create better outcomes for her clients.
    [Show full text]
  • History of the Australian Gene Patent Bill
    The Patenting of Biological Materials: A brief history of a concerted attempt to bring this practice to an end in Australia. Luigi Palombi Introduction In 2008 four Australian patents granted to Myriad Genetics were used by Genetic Technologies, a Melbourne company that had patented junk DNA and was also Myriad’s exclusive licensee, to try and do in Australia what Myriad had done in the United States - to monopolize the genetic testing for the human BRCA gene mutations linked to breast and ovarian cancers. With the patent ‘rights’ to these gene mutations, found on human genes BRCA 1 (located on human chromosome 17q) and BRCA 2 (located on human chromosome 13), Genetic Technologies could legally exclude anyone from making, using, selling or dealing with these gene mutations for any purpose for 20 years. On July 7 the company sent a letter to every Australian laboratory known to be providing BRCA gene testing to Australian patients. The letter, signed by its president, Michael B Obanessian, gave each of them 7 days to cease “using the Patents” and “refer the performance of all BRCA 1 and BRCA 2 testing” to the company or be sued for patent infringement. Mr Obanessian stressed the urgency of the threat: “Our lawyers have prepared a detailed Statement of Claim and are ready to file an Application with the Federal Court if necessary.” I am very pleased to advise that it never became necessary. What Mr Obanessian and Genetic Technologies hadn’t realized was that this letter, far from being a “warning shot fired across the bow”, as one patent attorney was to later describe it to a Senate Committee charged with investigating the impact of gene patents on the Australian healthcare system, lit a fuse - a fuse which is slowly sizzling towards its ultimate goal - the obliteration of patents over naturally occurring biological materials in Australia.
    [Show full text]
  • LETTER from CANBERRA Saving You Time
    LETTER FROM CANBERRA Saving you time. Three yearsLETTER on. After Letter from Melbourne, established FROM 1994. CANBERRA Saving you time. Three years on. After Letter from Melbourne, established 1994. A monthly newsletter distilling public policy and government A monthly decisions newsletter which distilling affect businesspublic policy opportunities and government in Australia decisions and beyond. which affect business opportunities in Australia and beyond. EDITORIAL INTERESTING POLITICALEDITORIAL CHALLENGES INTERESTING POLITICAL CHALLENGES The New South Wales election result shows that the AustralianThe New Labor South Party Wales needs election to renovate result itselfshows that the Australian Labor Party needs to renovate itself after such a significant defeat, a very big challenge. Whichafter challenge such a significant spreads well defeat, beyond a very NSW. big challenge. Which challenge spreads well beyond NSW. There are several areas of focus. First, Labor’s very origins,There values, are several objectives, areas and of focus. policies First, have Labor’s very origins, values, objectives, and policies have been replaced at a federal level, and in some recent statebeen campaigns, replaced at by, a federalsecondly, level, having and inan some recent state campaigns, by, secondly, having an emphasis on focus groups and the media, usually linkedemphasis in with battles on focus for groups marginal and seats. the media, This usually linked in with battles for marginal seats. This has all left Labor voters with little reason to vote the wayhas they all traditionallyleft Labor voters have. with little reason to vote the way they traditionally have. The ALP has had significant changes from its original manifesto,The ALP has including had significant the renovation changes of itsfrom its original manifesto, including the renovation of its socialisation platform.
    [Show full text]
  • Abstract the High Court in D'arcy V Myriad Genetics In
    Patenting Nucleic Acid Sequences: More Ambiguity from the High Court? Abstract The High Court in D’Arcy v Myriad Genetics Inc. recently addressed patent claims under the Patents Act 1990 (Cth) to deoxyribonucleic acid (DNA) sequences set out in tables listing nucleotides as As, Ts, Gs and Cs finding they are unpatentable. This was a significant development given DNA sequences have been patentable for decades. This article reviews the High Court’s various judgements highlighting the introduction of ambiguities to the current subject matter standards and providing a critique of the High Court majority’s assessment of DNA sequence as ‘information’. The article concludes that the High Court majority has introduced an unhelpful conception of ‘information’ as a standard for patentability. While this will limit claims to DNA and other nucleic acid sequences, the broader effect of the decision is uncertain because the High Court majority’s conception of ‘information’ could be applied to any matter (including all molecules) and eviscerate the patent system. 1. Introduction The vexed question of whether nucleic acids sequences (such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequences) should be patentable in Australia under the Patents Act 1990 (Cth) has attracted a large body of policy critique,1 scholarship,2 and unsuccessful legislative proposals.3 1 See Centre for International Economics, Economic Analysis of the Impact of Isolated Human Gene Patents, Final Report (IP Australia, 2013); Advisory Council on Intellectual Property, Patentable Subject Matter, Final Report (IP Australia, 2010); Community Affairs References Committee, Gene Patents (Senate Printing, 2010); Australian Law Reform Commission, Genes and Ingenuity: Gene Patenting and Human Health, Report 99 (ALRC, 2004); House of Representatives Standing Committee on Industry, Science and Technology, Genetic Manipulation: The Threat or the Glory? (AGPS, 1992) 224-243.
    [Show full text]
  • Ms Julie Dennett Committee Secretary Senate Legal and Constitutional Committee PO Box 6100 Parliament House Canberra ACT 2600 Australia
    Ms Julie Dennett Committee Secretary Senate Legal and Constitutional Committee PO Box 6100 Parliament House Canberra ACT 2600 Australia Dear Ms Dennett, Submission: Patent Amendment (Human Genes and Biological Materials) Bill 2010 In writing this submission, I commend Senator the Hon. Bill Heffernan for his long standing public advocacy on this issue.1 The monopolisation of the human genome by corporate interests should be seen in an equivalent fashion to the major infrastructure issue of the moment, the National Broadband Network (NBN). As observed by Martin, our DNA is: like a book with 23 chapters-one for each of our 23 pairs of chromosomes, which make up the gene material (macromolecule) found in the nuclei of cells. Each chapter is divided into sections-genes. You have about 30,000 genes. A typical gene has about 10,000 letters (called ‘nucleotides’ or ‘bases,’ each of which can be one of four combinations…It is amazing to think that the entire 23-chapter book is coiled up in the DNA double-helix molecule in every cell of your body.2 To continue the analogy, the coiled up double-helix could well be considered nature’s NBN. It is already laid down in every cell of our bodies and, has been there ever since we first appeared on Earth. It regulates how our bodies function, like a biological communications network, while variations in coding (wiring) give each individual person our unique characteristics. Yet, now corporations seek to ‘enclose’ various parts of our DNA, on the basis that they (the corporations) have developed methods to copy and extract parts of the chromosome.
    [Show full text]
  • Australia's Parliament House in 2014 and 2015: a Chronology of Events
    RESEARCH PAPER SERIES, 2016–17 23 DECEMBER 2016 Australia's Parliament House in 2014 and 2015: a chronology of events Anna Hough, Dr Joy McCann and Dr Dianne Heriot Politics and Public Administration Introduction Parliament House, which was officially opened in 1988, is the home of the Parliament of Australia. It is located on a 32-hectare site on Capital Hill in Canberra, the capital city of Australia. In 2013 the Parliamentary Library published a chronology of events, Australia’s Parliament House—more than 25 years in the making!, in recognition of the building’s 25th anniversary. This chronology continues the focus on Australia’s Parliament House, highlighting significant milestones associated with the building and the Parliament between January 2014 and December 2015. Appendix 1 presents a list of key legislation passed by the Commonwealth Parliament in 2014 and 2015. This chronology of events has been compiled from published sources and includes images and links to audio-visual and documentary records. Abbreviations AG Australian Greens ALP Australian Labor Party Hon. Honourable Ind Independent Lib Liberal Party of Australia NP The Nationals Retd Retired PUP Palmer United Party ISSN 2203-5249 2014 Milestones Details 11 February New senator for Queensland Senator Barry O’Sullivan (NP, Qld) is chosen by the Parliament of Queensland under Section 15 of the Constitution to represent that state in the Senate. He fills the casual vacancy created by the resignation of Barnaby Joyce MP (NP, New England, NSW) to stand for election to the House of Representatives in 2013. Senator O’Sullivan is sworn in on 13 February 2014 and makes his first speech on 19 March 2014.
    [Show full text]
  • Letter from Canberra Is a Sister Publication of Letter from Melbourne, Which Was Established 16 Years Ago
    LETTERSaving you time. A monthly newsletter distilling FROMpublic policy and government decisions CANBERRA which affect business opportunities in Australia and beyond. 5 JULY TO 7 AUGUST 2009 Issue No. 16: Post Ute-Gate/GFC Edition (Hopefully) Letter From Canberra is a sister publication of Letter From Melbourne, which was established 16 years ago INSIDE Australian Fair Broadband Rudd guilty ‘The very Throwing the The difference Emissions Health system Pay Commission developments of Camelcide strange Godwin book at the between trading: suggested freezes wages Grech’ Productivity Iraq and vote close, changes. A big Commission Afghanistan agreement far job. NEXT MONTH Mulesings Australian ships 5 JULY TO 7 AUGUST 2009 14 Collins Street Melbourne, 3000 Victoria, Australia P 03 9654 1300 EDITORIAL F 03 9654 1165 [email protected] Q&A is an ABC TV weekly event, vintage on Thursday 6 August, when Deputy prime minister Julia Gillard and www.letterfromcanberra.com.au Opposition leader Malcolm Turnbull were on the panel with the whole audience, and three of the six person panel, being under 25. As the two leaders debated the rights and wrongs of Ute-Gate on the head of a pin, NextGen said ‘Move On’, that Ute-Gate was distracting from bigger issues such as education and health and almost everything else. Editor Alistair Urquhart Associate Editor Rick Brown The International Student Crisis, ISC, linked as it is with immigration and international trade, is an awakening Sub-Editor Hamish Brooks difficulty for Australia, the gravity still to flow through. Copy-Editor Robyn Whiteley Subscription Manager Andrea Hodgkinson Design Ray Zhang Camels hit the headlines for a day or so in the Australian press and became a news/mockstory/spoof in the United States media, when Prime Minister Rudd featured.
    [Show full text]
  • Ditch the Witch: Julia Gillard and Gender in Australian Public Discourse
    Ditch The Witch: Julia Gillard and gender in Australian public discourse. Marian Woodward Marian Elizabeth Woodward SID 307152111 A thesis submitted in partial fulfilment of the requirements for the degree of Bachelor of Arts (Honours) Department of Gender and Cultural Studies October 2013 2 Acknowledgements I wish to thank My grandmother, Dr Lyn Riddett. My supervisors, Professor Elspeth Probyn, Associate Professor Natalia Lusty and Dr Fiona Probyn-Rapsey. Dr Ruth Barcan and Associate Professor Kane Race for their kindness and support as Honours Coordinators. The siX women members of parliament who met with me early in my Honours year to discuss their thoughts on gender and politics in Australia. My family, in particular Geraldine & Alison, and also Luke, Louise and Seirah. Thanks to Karey and Prince for the walks, and to Effie for the eXcellent proof reading. Thanks to Roselle Sy for the hard stuff. And a very special thank you to Tim, Bailey and Dylan – my favourites. Cover illustration by Jeff Fisher. Source: http://www.themonthly.com.au/issue/ 2010/august/1357605992/julia-baird/comment. 3 Statement of originality I certify that to the best of my knowledge the content of this thesis is my own work and that all the assistance received in preparing this thesis and sources have been acknowledged. This thesis has not been submitted for any other degree or purpose. Marian Woodward 18 October 2013 4 Abstract This thesis eXplores the interplay of gender, media, politics and women’s political representation in Australia. I eXamine how the Australian media has tended to reinforce rather than challenge dominant cultural aspects of Australian politics.
    [Show full text]
  • Report: Air Navigation and Civil Aviation Amendment (Aircraft Crew
    Dissenting Report by Coalition Senators Coalition Senators note in relation to Recommendation 2 1.1 The management of private companies and decisions determined during the course of running their business should be the exclusive remit of that company. Government, or indeed any party, should not sit in subjective judgement to negotiate on, and interfere with, management decisions unrelated to the functions of that party. 1.2 This recommendation would constrain management’s capacity and flexibility to effectively function in the market place. 1.3 This recommendation illegitimately impinges on a company's ability, specifically in this case Qantas, to make decisions in order to facilitate the effective management and running of their business. 1.4 It is for this reason that it should not be supported by the Committee and is opposed by the Coalition. An individual or any other business entity should not be subjected to any legislation that removes their pre-eminent and indisputable right to run itself. 1.5 Further, the aviation safety culture is often held up as a benchmark, due in large part to its "no-blame" (sometime called "just culture") approach to encouraging open reporting. Aviation safety management systems encourage, if not require, employees or management at any level to be prepared to highlight an actual or potential safety issue, even if that means interruptions to planned operations until the issue is investigated. 1.6 The Civil Aviation Act 1988 (Section 28E) place specific requirements upon the holder of an Air Operators Certificate (AOC) in regards to safety. Civil Aviation Orders (CAO) 82.3 and 82.5 supported by Civil Aviation Advisory Publication (CAAP) SMS-1(0) expand on the specific requirements of a safety management system for regular transport operations.
    [Show full text]
  • Under the Radar
    THE AUSTRALIA INSTITUTE Under the Radar Dog-whistle politics in Australia Josh Fear Discussion Paper Number 96 September 2007 ISSN 1322-5421 ii © The Australia Institute This work is copyright. It may be reproduced in whole or in part for study or training purposes only with the written permission of the Australia Institute. Such use must not be for the purposes of sale or commercial exploitation. Subject to the Copyright Act 1968, reproduction, storage in a retrieval system or transmission in any form by any means of any part of the work other than for the purposes above is not permitted without written permission. Requests and inquiries should be directed to The Australia Institute. The Australia Institute iii Table of contents Table of contents iii Acknowledgments iv Summary v 1. Introduction 1 1.1 What is dog whistling? 1 1.2 Does dog whistling really exist? 2 1.3 Outline 3 2. A history and theory of dog whistling 4 2.1 Etymology and usage 4 2.2 A working definition 5 2.3 Types of dog whistling 7 2.4 Intention versus interpretation 10 2.5 The role of metaphor in political communication 12 3. Dog whistling in practice 17 4. Dog whistling in context 21 4.1 Dog whistling and democracy 21 4.2 Us and them 22 4.3 Border protection, national security and the politics of race 25 5. Dog whistling and the media 31 5.1 The news cycle 31 5.2 Media representation of race and religion 31 5.3 Right-wing commentators 33 5.4 Narrowcasting 35 6.
    [Show full text]
  • Increasing Use of So-Called Flag of Convenience Shipping in Australia
    The Senate Rural and Regional Affairs and Transport References Committee Increasing use of so-called Flag of Convenience shipping in Australia Interim report May 2016 © Commonwealth of Australia 2016 ISBN 978-1-76010-433-7 This document was prepared by the Senate Standing Committee on Rural and Regional Affairs and Transport and printed by the Senate Printing Unit, Department of the Senate, Parliament House, Canberra. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Australia License. The details of this licence are available on the Creative Commons website: http://creativecommons.org/licenses/by-nc-nd/3.0/au/. Membership of the committee Members Senator Glenn Sterle, Chair Western Australia, ALP Senator the Hon Bill Heffernan, Deputy Chair New South Wales, LP Senator Joe Bullock (to 13 April 2016) Western Australia, ALP Senator Alex Gallacher (from 18 April 2016) South Australia, ALP Senator Sue Lines Western Australia, ALP Senator Peter Whish-Wilson Tasmania, AG Senator John Williams New South Wales, NATS Other Senators participating in this inquiry Senator Sean Edwards South Australia, LP Senator John Madigan Victoria, IND Senator Barry O'Sullivan Queensland, NATS Senator Janet Rice Victoria, AG iii Secretariat Mr Tim Watling, Secretary Ms Bonnie Allan, Principal Research Officer Ms Erin East, Principal Research Officer (to 24 November 2015) Mr Nicholas Craft, Principal Research Officer (from 12 October 2015) Dr Jane Thomson, Principal Research Officer (to 6 July 2015) Ms Trish Carling, Senior
    [Show full text]